OpenFilings
Oruka Therapeutics, Inc.
Form
8-K
Report Period
2026-04-27
Date Filed
2026-04-30
Time Filed
16:17:27
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
UNDERWRITING AGREEMENT BY AND AMONG ORUKA THERAPEUTICS, INC. AND LEERINK PARTNER
OPINION OF DAVIS POLK & WARDWELL LLP
EXCERPT FROM PRELIMINARY PROSPECTUS SUPPLEMENT DATED APRIL 27, 2026
Filing on SEC Edgar